Understand the source comparison
LL-37 for Immune System Optimization: Research vs Commercial Application
Mechanism Vitamin D-dependent transcription via CAMP gene Direct peptide delivery bypasses transcription pathway Undefined. Often amino acid blends marketed as 'immune support' Only vitamin D upregulation and synthetic peptide administration have mechanistic e
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Mechanism
- Vitamin D-dependent transcription via CAMP gene
- Direct peptide delivery bypasses transcription pathway
- Undefined. Often amino acid blends marketed as 'immune support'
- Only vitamin D upregulation and synthetic peptide administration have mechanistic evidence
- Typical Serum Range
- 2–5 μg/mL in healthy adults
- Dose-dependent. Research protocols use 10–50 μg/mL topically or subcutaneously
- Not measured. No bioavailability data
- Exogenous dosing achieves concentrations unattainable through endogenous production
- Antimicrobial Efficacy
- Effective against Gram-positive and Gram-negative bacteria, some viruses
- Identical to endogenous. Synthetic structure matches native sequence
- No validated antimicrobial data
- Synthetic LL-37 replicates endogenous function when amino acid sequence is exact
- Regulatory Pathway
- Naturally occurring. Not regulated as a drug
- Investigational. Research-grade peptides are not FDA-approved for clinical use
- Sold as dietary supplements. No FDA oversight
- Synthetic peptides exist in a regulatory gray area between research tools and unapproved therapeutics
- Clinical Evidence
- Observational studies correlating deficiency with infection rates
- Phase I/II trials in wound healing and periodontal disease show safety and preliminary efficacy
- None. No peer-reviewed trials
- Endogenous production data is robust; exogenous use is early-stage but mechanistically sound
- Commercial 'immune peptide' products rarely specify LL-37 content or provide amino acid sequencing data. Most are marketed blends that include thymosin alpha-1, beta-glucans, or colostrum extracts. These may have general immune-modulating effects, but they do not replicate LL-37's specific mechanism. Real Peptides synthesizes peptides with exact amino-acid sequencing verified by mass spectrometry, which is the standard required for research-grade compounds.